Trump administration tries again to institute rebates in 340B

RegulatoryNegative

AI Analysis

Summary

The Trump administration's HRSA is renewing efforts to include rebates in the 340B drug discount program following a failed attempt earlier this year, prompting hospitals to voice opposition citing financial burdens.

Outcome Details

HRSA pushing to include rebates in 340B drug discount program

Importance:3/10

Sentiment:

-0.60

340B_programdrug_pricingrebateshospital_reimbursementregulatory_policy

Related Companies

$HIT

Read the original article

Published by BioPharma Dive on July 31, 2026 7:10 PM

Read Original